ALC
Asset Logo

Alcidion Group Limited

πŸ‡¦πŸ‡Ί ASX

🩺 HEALTH CARE

Compare
Add to watchlist
πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

-13.20%
Annual Growth

5 years average annual growth

πŸ’΅

$ 500
Minimum Order

Due to regulatory requirements

🌏

47
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

Alcidion Group Ltd. engages in the development and provision of healthcare software products marketed under the Miya, Patientrack, Smartpage and ExtraMed brands. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-06-24. The firm's principal activities include the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of selected healthcare software products from its strategic partners and the delivery of product implementation, product support and maintenance, systems integration, and data analysis services to healthcare customers in Australia, New Zealand, and the United Kingdom. Its product, Miya Precision, is a smart clinical solution based on a FHIR-event platform that facilitates multiple clinical and operational applications. The firm's other products include Smartpage, Patientrack, and Silverlink PCS. Smartpage is an advanced smartphone and Web-based system for hospital communication and task management, addressing the requirements of both clinical and non-clinical users.

πŸ“ˆ Performance

Price History

+205.81%

1M

1Y

10Y

Graph

Table

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ’° Price*

$0.06

*Price may be up to 24 hours old

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in ALC

47

πŸ“Š Total Capital Earnings

$63K

πŸ”ƒ Average investment frequency

35 weeks

πŸ’΅ Average investment amount

$2,558

⏰ Last time a customer invested in ALC

29 days
ALC investor breakdown
πŸ’΅ Income of investors

More than 200k

150k - 200k

100k - 150k

11%

50k - 100k

41%

Less than 50k

33%
πŸ‘Ά Age of investors

18 - 25

26 - 34

26%

35 - 90

70%
πŸ™‹ Legal gender of investors

Female

32%

Male

68%

Pearlers who invest in ALC also invest in...

Vanguard Australian Shares Index ETF

VAS

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

3.40%

πŸ“Š Share price

$101.14 AUD

πŸ‡¦πŸ‡Ί AUSTRALIA

⛳️ DIVERSIFIED

🧱 MATERIALS

πŸ’Έ FINANCIALS

Find Out More

NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.

πŸ™Œ Performance (5Yr p.a)

27.61%

πŸ“Š Share price

$50.89 AUD

πŸ‡ΊπŸ‡Έ UNITED STATES

πŸ“ˆ HIGH PRICE GROWTH

πŸ€– TECHNOLOGY

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

14.00%

πŸ“Š Share price

$140.11 AUD

⛳️ DIVERSIFIED

πŸ“ˆ HIGH PRICE GROWTH

🌏 GLOBAL

πŸ€– TECHNOLOGY

IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

πŸ™Œ Performance (5Yr p.a)

20.54%

πŸ“Š Share price

$63.54 AUD

πŸ“ˆ HIGH PRICE GROWTH

πŸ‡ΊπŸ‡Έ UNITED STATES

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

3.73%

πŸ“Š Share price

$68.73 AUD

🌏 GLOBAL

⛳️ DIVERSIFIED

Want more shares? Try these...

Ampol Ltd. engages in the supply of transport fuels. The company is headquartered in Alexandria, New South Wales and currently employs 3,152 full-time employees. The firm supplies petrol and a convenience network, as well as refining, importing and marketing fuels and lubricants. The company also launched its electric vehicle charging and home electricity solutions. The firm supplies fuel to approximately 80,000 customers in diverse markets across the Australian economy, including defense, mining, transport, marine, agriculture, aviation and other commercial sectors. Across its retail network, the Company serves approximately three million customers every week with fuel and convenience products, as well as electric vehicle charging at selected locations. Its customer base is supported by its robust supply chain and strategic infrastructure positions across the country, which includes 16 terminals, six pipelines, 55 wet depots, over 1,800 branded sites and one refinery located in Lytton, Queensland. This network is supported by over 8,300 people across Australia and overseas.

πŸ™Œ Performance (5Yr p.a)

-4.14%

πŸ“Š Share price

$27.07 AUD

πŸ’° HIGH DIVIDEND

⚑️ ENERGY

πŸ•ŠοΈ SOCIALLY AWARE

Argo Global Listed Infrastructure Ltd is a AU-based company operating in industry. The company is headquartered in Sydney, New South Wales and currently employs 0 full-time employees. The company went IPO on 2015-07-03. Argo Global Listed Infrastructure Limited is an investment company. The company provides investors with the opportunity to invest in a diversified portfolio of listed global infrastructure securities, with the primary objective of providing shareholders with long-term capital growth and dividend income. Its portfolio is diversified across 50-70 global listed infrastructure securities across various subsectors and geographies, including both emerging and developed economies. Its portfolio only includes listed companies that derive at least 70% of revenues from, or have at least 70% of assets committed to, the construction, development or financing of infrastructure assets, or the management, ownership and/or operation of infrastructure assets. Its subsector diversification includes electric, midstream energy, gas distribution, airports, railways, communications, marine ports, toll roads, environmental services, and others. Its portfolio manager is Cohen & Steers Capital Management, Inc.

πŸ™Œ Performance (5Yr p.a)

-0.51%

πŸ“Š Share price

$2.29 AUD

Arovella Therapeutics Ltd. engages in the development invariant Natural Killer (iNKT) cell platform for treatment of cancer. The firm is focused on developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumors. The firm's lead product is ALA-101. ALA-101 is being developed as an allogeneic cell therapy, which means it can be given from a healthy donor to a patient. ALA-101 is a next-generation CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukemias. ALA-101 consists of CAR19-iNKT cells that have been modified to produce a Chimeric Antigen Receptor (CAR) that targets CD19. CD19 is an antigen found on the surface of numerous cancer types. The firm is also engaged in expanding solid tumor treatment through its CLDN18.2-targeting technology licensed from Sparx Group. Its iNKT cells also contain an invariant T cell receptor (iTCR) that targets alpha-galactosylceramide (a-GalCer) bound CD1d, another antigen found on the surface of several cancer types.

πŸ™Œ Performance (5Yr p.a)

46.89%

πŸ“Š Share price

$0.17 AUD

πŸ“ˆ HIGH PRICE GROWTH

πŸ“¦ LOGISTICS

Albion Resources Ltd. is focused on exploration for lead, zinc, gold, and nickel. The company is headquartered in Perth, Western Australia. The company went IPO on 2021-04-30. The firm's projects include Mongers Lake Project, Leinster Project and Lennard Shelf Project. The Mongers Lake Project covers a portion of the Yalgoo-Singleton Greenstone Belt in the Murchison Province of Western Australia, located between Capricorn Metals’ Mt Gibson Gold Project and Silver Lakes’ Rothsay Gold Projects. The firm has identified three prospect areas: Rothsay South, Red Well and Clay Pan. The Leinster Project, located 30 kilometers (kms) southeast of Leinster, covers an area of approximately 42 square kilometers (km2) and is prospective for nickel-copper being located adjacent to BHP's Nickel West Weebo Ni deposit. The Lennard Shelf Project is located in the Mississippi Valley type Zinc-Lead province, the Lennard Shelf, approximately 30 kms southeast of Fitzroy Crossing in the Kimberley, Western Australia.

πŸ“Š Share price

$0.04 AUD

⛏️ MINING

Compare
Add to watchlist